Navigation Links
/C O R R E C T I O N -- Rosetta Genomics Ltd/
Date:5/21/2008

ess highlights.

The 2008 first-quarter net loss of $3.9 million (including a non-cash expense of $191,000 related to stock based compensation), or $0.33 per ordinary share. The first-quarter result compares with a net loss of $2 million (including a non-cash expense of $205,000 related to stock based compensation), or $0.23 per ordinary share, for the corresponding quarter of 2007.

"This has been a remarkable quarter for us at Rosetta Genomics on both the business and scientific fronts," said Amir Avniel, President and CEO of Rosetta Genomics. "We have continued the rapid advancements towards the launch of the first diagnostic tests based on our microRNA technology, and look forward to the exciting events that lay ahead of us in the following months."

On the business front, Rosetta Genomics recently announced that Columbia University Medical Center's Molecular Pathology Laboratory has submitted the first microRNA-based test based on the company's microRNA technology for regulatory approval to the New York State Department of Health. The test is designed to differentiate squamous from non squamous non-small cell lung cancer (NSCLC) and is the first of three tests the company expects will be submitted for regulatory approval by CLIA certified labs in 2008.

In addition, the company recently announced an agreement with the University of California, Irvine School of Medicine to develop diagnostic tests based on Rosetta's proprietary microRNA technology.

On the scientific front, in a paper published in the April issue of Nature Biotechnology, Rosetta Genomics and collaborators demonstrated the significant potential of microRNAs to be used as biomarkers for diagnosing the primary tumor site in patients with cancer of unknown primary (CUP). The company expects a CUP test based on its microRNA technology to be submitted for regulatory approval by a CLIA certified lab by the end of 2008.

Financial Overview

Operating loss for th
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26 August 2014 - A team of engineers ... ZigBee wireless sensor network (WSN) for satellite communications. ... major constraint in satellite design, constructing a lightweight, ... with cabling inside the satellite has always been ... team at the Satellite Research Centre of Nanyang ...
(Date:8/26/2014)... Aug. 26, 2014  ViveBio, LLC a leading ... stabilization and transportation, announced today that it has ... LLC (LPS) of Knoxville, Tennessee ... the United States . ViveST ... ambient temperature dried biological specimen transport systems.  The ...
(Date:8/26/2014)... Vycom announced today that Modutek ... chemical process equipment, has selected its Flametec materials for ... Rare Isotope Beams (FRIB). This involved the creation ... with Vycom’s Flametec PVC-C and Kytec PVDF material to ... of FRIB’s linear accelerator (known as LINAC). ...
(Date:8/26/2014)... CITY, Calif. , Aug. 26, 2014 /PRNewswire/ ... development and commercialization of oncology diagnostic products, has ... as a 2015 Technology Pioneer . As ... is one of 24 companies across a wide ... prestigious accolade. Guardant360 ® , ...
Breaking Biology Technology:ZigBee in the Sky 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2
... specialists has completed their first successful content migrations to the ... global chemical manufacturing company and a multinational biotechnology company. ... ... 2008 -- Impact Systems Inc., ( www.impactinfosys.com ), a leading ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA.OB) ("Duska" ... is available via Standard & Poor,s,Corporation Records Listing ... of Duska Therapeutics is published in the Daily ... manual for secondary,trading in approximately 38 states under ...
... 26 ValGenesis, Inc., a leading,provider of ... availability of ValGenesis 2.0, the latest version ... cycle,management and automation product., Life science ... manage the entire validation life cycle and ...
Cached Biology Technology:Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 2Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 3Duska Therapeutics Obtains Standard & Poor's Listing 2ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 2ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 3
(Date:8/25/2014)... willpower to avoid becoming obese or to slim ... of minority groups, maintaining a healthy weight can be ... Luis Rivera, an experimental social psychologist at Rutgers University-Newark. ... the United States to endure negative stereotypes, pervasive messages ... attitudes can prevent people from doing what is needed ...
(Date:8/25/2014)... 1 in 6 adults worldwide may suffer from ... cause serious complications. Auriculotherapy, a form of acupuncture ... ear, may help in managing constipation. Evidence from ... the effectiveness of auriculotherapy in treating patients with ... article in The Journal of Alternative and ...
(Date:8/25/2014)... with the completion of a new study. , Scientists ... cells in a living animal for the first time. ... organ next to the heart that produces immune cells ... against disease. , They hope that, with further research, ... with a weakened immune system. , The team ...
Breaking Biology News(10 mins):Racial and ethnic stereotypes may contribute to obesity among minorities 2Scientists first to grow organ in animal from cells created in lab 2
... mutation that causes X-linked mental retardation for which there ... article to be published electronically on Tuesday, March 20, ... , Investigators F. Lucy Raymond (Cambridge Institute of Medical ... Tarpey (Wellcome Trust Sanger Institute, Hixton, UK) describe the ...
... of California, San Diego and the University of Bonn ... plant species richness. Covering several hundred thousand species, the ... map of the distribution of biodiversity on Earth to ... in this week's early online issue of the journal ...
... HIV-infected patients in Uganda who self-paid for their antiretroviral ... financial demands or supply logistical disruptions. These treatment ... medications in patients. , These findings by a team ... Makerere University, Kampala, and UCSF are reported in the ...
Cached Biology News:Severe mental retardation gene mutation identified 2Biologists produce global map of plant biodiversity 2Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2
... The new D-LUX Detection Platform ... to provide the most sensitive, specific, ... qPCR. Invitrogens D-LUX Detection Platform offers ... equal to TaqMan probes, high signal/background ...
...
Request Info...
... Blood is aseptically collected via cardiac puncture ... Zealand White, mixed sex). It is then centrifuged ... pooled, sterile filtered and bottled at 4C then ... IF YOU HAVE ALWAYS USED PEL-FREEZ COMPLEMENT, YOU ...
Biology Products: